Introduction: Acute myocardial infarction (MI) significantly contributes to mortality and morbidity in developed and developing countries. ECG can readily diagnose ST-elevation myocardial infarction (STEMI) to allow myocardium-saving interventions; however, ECG is not effective for diagnosing patients with non-ST-elevation myocardial infarction (NSTEMI).
Introduction
Acute myocardial infarction (MI) significantly contributes to mortality and morbidity in developed and developing countries. To reduce mortality and morbidity, rapid clinical determination of the likelihood of obstructive coronary artery diseases with subsequent management is necessary for all patients with chest discomfort or other symptoms suggestive of an acute coronary syndrome (ACS). 1e3 Timely procession from the emergency department (ED) through to hospital discharge improves the outcome for ACS patients. 4 Although there are increasing numbers of methods with which to diagnose acute MI, electrocardiography (ECG) is considered a quick, easily accessible tool, and is the single most important initial clinical test for diagnosing myocardial ischemia and MI. 5 A 12-lead ECG has been at the center of decision-making for patients with chest pain for whom ischemia is suspected since 1997. 6 ST-segment elevation MI (STEMI) can easily be diagnosed from clinical manifestation and typical ECG changes. With STEMI, the on-duty cardiologist can be notified early when the patient is brought to the ED. However, non-STsegment elevation MI (NSTEMI) requires further workup and observation. The cardiologist is usually called when the patient is persistently symptomatic despite treatment, especially when elevated cardiac markers are subsequently reported. We conducted this study to compare NSTEMI and STEMI patients in a search for useful clues that may help in early diagnosis of NSTEMI in the ED.
Methods
This is a tertiary referral center with an annual census of 105,000 emergency visits. We retrospectively reviewed ED patients aged 18 years or older who received primary percutaneous coronary intervention (PCI) from January 1, 2009 to May 31, 2010 after obtaining permission from our Institutional Review Board. Acute MI was diagnosed based on clinical manifestation, ECG, and an increase in cardiac marker levels. Patients who had been previously enrolled in this study were not eligible for re-enrollment. Acute MI patients were classified as either STEMI or NSTEMI based on the ECG. Data on demographic characteristics, body mass index, major risks for coronary artery diseases (CAD), co-morbidities, ECG, echocardiogram, angiographic findings, interventions, and 30-day short-term outcomes were collected. We used Student's t-test for continuous variables, a c 2 test for categorical variables, and multivariate logistic regression analysis for risk factors in comparing STEMI and NSTEMI patients; p < 0.05 was defined as statistically significant.
Results
There were 417 patients who received PCI, 175 (42.0 %) of whom were diagnosed as having acute MI. Of these, 168 patients were enrolled for analysis after excluding those who were transferred back to another facility after intervention or who were lost during follow-up. Of the study patients, 104 (61.9%) were diagnosed with STEMI and 64 (38.1%) with NSTEMI ( Table 1 ). The male/female ratio was greater in STEMI (4.0 vs. 1.9; p ¼ 0.041). There were no differences in age, length of stay, or body mass index between STEMI and NSTEMI patients. Although major CAD risks and chest pain were more frequent among STEMI patients, the differences did not reach statistical significance (CAD risks: 2.6 AE 1.0 in STEMI, 2.2 AE 1.1 in NSTEMI, p ¼ 0.191; chest pain: 85.6% in STEMI, 75.0% in NSTEMI, p ¼ 0.086). With regard to comorbidities apart from major CAD risks, more NSTEMI patients needed replacement dialysis for end-stage renal disease ( p < 0.001) or had cerebrovascular diseases ( p ¼ 0.030), but there was no difference in malignancy, chronic kidney diseases, or atrial fibrillation. More NSTEMI patients had received coronary intervention before the index MI (21.9% vs. 8.7%, p ¼ 0.015). It was difficult to compare previous coronary artery bypass surgery because of the limited number of relevant cases.
Identification of ST-segment elevation in body-surface ECGs is straightforward; however, NSTEMI patients had various and sometimes ambiguous ECG findings ( Table 2) . Among NSTEMI patients, 22 (34.4%) had ST depression that may have been true ST depression or reciprocal changes. Forty-two had other ECG changes, including T-wave abnormalities (n ¼ 33; 51.6%), poor R-wave progression (n ¼ 4; 6.3%), atrial fibrillation (n ¼ 3; 4.7%), bundle branch block (n ¼ 2; 3.1%), frequent premature ventricular activity (n ¼ 1; 1.6%), and asystole (n ¼ 1; 1.6%). In one patient, no change could be identified (1.6%).
On echocardiographs, NSTEMI patients had fewer instances of and milder wall-motion abnormality ( p ¼ 0.0045). Coronary angiography revealed that the left anterior descending (LAD) artery was the most common culprit artery in both STEMI (54.8%) and NSTEMI patients (40.6%); however, the left circumflex (LCx) artery played a more important role in NSTEMI (28.1%) than in STEMI patients (4.7%; p < 0.001).
With regard to short-term outcome, MI and peripheral artery diseases were more frequent in NSTEMI patients, whereas more deaths occurred in STEMI patients. However, these differences did not reach statistical significance (Table 3) .
Discussion
"Time is myocardium, myocardium is life" is an aphorism that captures the urgency required in MI diagnosis. Early reperfusion of an obstructed coronary artery can reduce both mortality and morbidity from acute MI. Primary PCI is the preferred reperfusion therapy if it can be performed by an experienced cardiologist within 90 minutes of the first medical contact, especially for patients with STEMI. 7, 8 Thrombolytic therapy in a timely manner is an alternative in the pre-hospital setting, or when primary PCI is not available in the receiving hospital. 9,10 Facilitated PCI is a combination of quick-start clot-dissolving medication followed by primary PCI; this can result in more complete ST-segment resolution in STEMI, although improved outcomes have not been proven in comparison with primary PCI. 11, 12 All of the above approaches involve rapid diagnosis and treatment.
The results of our study demonstrate that acute MI remains a disease of middle-aged adults. Although three-quarters of our patients were male, more NSTEMI patients were female. Before the index MI, our NSTEMI patients had significantly more cardiac, cerebrovascular, and end-stage renal diseases, in agreement with the literature. 13, 14 These patients presented more frequently without chest pain. Although these differences did not reach statistical significance in our study, a high index of suspicion is warranted for patients potentially experiencing a silent MI. There were no differences in age, major CAD risks, body mass index, malignancy, or atrial fibrillation.
Although 12-lead body-surface ECG is a simple examination, it stands at the center of decision-making for patients with chest pain for whom ischemia is suspected. It can be used as a screening tool because a significant segment of the acute MI patient population presents without chest pain. 15, 16 A 12-lead ECG can be used to stratify risk, identify the infarct-related coronary artery, and predict outcomes in some cases. 6, 17, 18 Although ECG interpretation of ST elevation or depression is straightforward, there are several subtle ECG changes of which physicians need to be aware for early diagnosis of acute MI. Prominent T waves may be the only ECG abnormality in the early stage of STEMI, although some other conditions such as hyperkalemia, left ventricular hypertrophy, and early repolarization need to be differentiated. 19, 20 Acute MI with bundle branch block (BBB) carries a much worse prognosis than acute MI without BBB. 21 A left BBB is notorious in masking ischemic changes in acute MI. 22 A right BBB, although once thought not to mask the diagnosis of acute MI, causes even more interference. 23 It has been reported that abnormal T waves, especially T-wave inversions of >5 mm, in patients with potential ACS are associated with higher rates of cardiovascular events. 24 Aside from the above ECG abnormalities, some of our NSTEMI patients had less obvious T-wave changes. These ECG changes, although subtle, could be identified when a series of ECGs were obtained to check for evolving changes. 25, 26 Aside from the 12-lead ECG, echocardiography is another easily accessible bedside examination that can increase the sensitivity of MI diagnosis, especially in locations supplied by the distal RCA and some branches from the LCx that are not monitored by any standard ECG leads. 27 Echocardiography, with a stress echo as required, is helpful when the ECG is equivocal or complications of acute MI are suspected. 28, 29 Laboratory measurement of a troponin or sensitive troponin I assay can provide additional information for the early diagnosis of acute MI. 30, 31 Coronary arteriography showed that the LAD was the major culprit coronary artery in the context of MI among our patients. However, there was a greater LCx contribution in NSTEMI compared to STEMI patients. The infarction territory was less extensive in NSTEMI than in STEMI patients, and less wall-motion abnormality was observed, as revealed by echocardiography. However, the short-term prognosis was no better in patients with NSTEMI than in those with STEMI. This suggests that NSTEMI patients have prognoses similar to those of STEMI patients, so they should be treated as seriously as STEMI patients. 1, 13, 14 
Limitation
This was a retrospective cohort study of patients with a discharge diagnosis of acute MI. We found some important clinical manifestations, co-morbidities, and ECG abnormalities in NSTEMI patients. However, it is not necessary to treat these clinical manifestations as risk factors before more patients with these characteristics but without acute MI are enrolled.
Patients enrolled in the study came from a single hospital. A regional, or even national, study should be undertaken before the results can be extrapolated to the general population. 
Conclusion
Early diagnosis is the first step in successful treatment of acute MI. Although new diagnostic methods are continuously evolving, the 12-lead body-surface ECG, a quick and easily accessible test, remains the single most important initial clinical test for myocardial ischemia and MI. STEMI patients can be managed without difficulty; however, this is not usually the case for NSTEMI patients. Serial ECGs should always be obtained for comparison. Expert consultation, with bedside echocardiography and laboratory measurement of cardiac markers, should be undertaken without delay once dynamic ECG changes are found, even if subtle, especially in patients with multiple co-morbidities.
